Raising good cholesterol to resist neuromuscular disease
Preclinical research published in PLOS One shows potential for decreasing the risk of heart failure in Friedreich's ataxia patients, and will move forward with trials to determine whether raising HDL levels, or "good cholesterol" by administering statins will reduce their cardiovascular risk.
FULL STORY AT Penn Medicine News →